Your browser doesn't support javascript.
loading
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.
Kato, Ken; Shah, Manish A; Enzinger, Peter; Bennouna, Jaafar; Shen, Lin; Adenis, Antoine; Sun, Jong-Mu; Cho, Byoung Chul; Özgüroglu, Mustafa; Kojima, Takashi; Kostorov, Vladimir; Hierro, Cinta; Zhu, Ying; McLean, Lee Anne; Shah, Sukrut; Doi, Toshihiko.
Afiliación
  • Kato K; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Shah MA; Weill Cornell Medical College, New York Presbyterian Hospital, 1305 York Avenue, Room Y1247, New York, NY 10065, USA.
  • Enzinger P; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215-5450, USA.
  • Bennouna J; University Hospital of Nantes, Digestive Oncology, 1 Place Alexis Ricordeau, Nantes, 44000, France.
  • Shen L; Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian District, Beijing, 100142, PR China.
  • Adenis A; Institut du Cancer de Montpellier, 208 Avenue des Apothicaries, Montpellier, 34298, France.
  • Sun JM; Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Seoul, Republic of Korea.
  • Cho BC; Severance Hospital, Yonsei University Health System, 50-1 Yonsei-ro, Seoul, Republic of Korea.
  • Özgüroglu M; Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Koca Mustafa Pasa Mahallesi, Cerrahpasa Caddesi No. 53, Istanbul, 34096, Turkey.
  • Kojima T; National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, 277-8577, Japan.
  • Kostorov V; Leningrad Regional Oncology Dispensary, Ulitsa Savushkina, 126, Saint Petersburg, 197374, Russian Federation.
  • Hierro C; Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology (VHIO), 119-129 Pg vall d'Hebron, Barcelona, 08035, Spain.
  • Zhu Y; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • McLean LA; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • Shah S; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • Doi T; National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, 277-8577, Japan.
Future Oncol ; 15(10): 1057-1066, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30735435
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido